PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.300
+0.010 (0.78%)
Apr 2, 2025, 4:00 PM EDT - Market closed

PharmaCyte Biotech Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2015 - 2019
Market Capitalization
91851484236
Upgrade
Market Cap Growth
-40.73%-64.81%5.50%14.27%16.41%-21.44%
Upgrade
Enterprise Value
-8-20-22-383936
Upgrade
Last Close Price
1.292.122.922.3326.5736.75
Upgrade
PB Ratio
0.220.400.700.546.337.13
Upgrade
P/TBV Ratio
0.290.690.740.5613.5023.58
Upgrade
Debt / Equity Ratio
----0.010.04
Upgrade
Quick Ratio
14.0331.60115.99121.243.040.87
Upgrade
Current Ratio
14.2031.76116.18121.383.141.01
Upgrade
Return on Equity (ROE)
42.89%0.57%-5.31%-8.78%-60.35%-75.57%
Upgrade
Return on Assets (ROA)
-4.89%-6.12%-4.92%-5.60%-33.37%-40.03%
Upgrade
Return on Capital (ROIC)
-5.96%-6.90%-4.96%-5.68%-37.71%-46.36%
Upgrade
Earnings Yield
112.21%1.86%-8.47%-8.78%-8.40%-10.54%
Upgrade
Buyback Yield / Dilution
35.50%50.84%-25.56%-971.73%-60.24%-23.23%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q